Quantitation of Response to Therapy in Calcium Urolithiasis

Overview

Journal Urol Res

Specialty Urology

Date 1979 Sep 1

PMID 388797

Authors

J E Zerwekh

O Lawoyin

C Y Pak

Affiliations

Soon will be listed here.

Abstract

The physico-chemical basis for the action of various drugs in calcium nephrolithiasis may be described in terms of changes produced in the urinary state of saturation (APR), limit of metastability (FPR), or in crystal growth. The validation of this scheme for drug action requires further correlation of objective responses to drug therapy, described in terms of urinary crystallisation, with the clinical response.

References

VERMEULEN C, Lyon E, GILL W . ARTIFICIAL URINARY CONCRETIONS. Invest Urol. 1964; 1:370-86. View

Pak C, RUSKIN B, Diller E . Enhancement of renal excretion of zinc by hydrochlorothiazide. Clin Chim Acta. 1972; 39(2):511-7. DOI: 10.1016/0009-8981(72)90080-0. View

Oata M, Pak C . The effect of diphosphonate on calcium phosphate crystallization in urine in vitro. Kidney Int. 1973; 4(6):401-6. DOI: 10.1038/ki.1973.136. View

Pak C . Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J Clin Invest. 1969; 48(10):1914-22. PMC: 322428. DOI: 10.1172/JCI106158. View

Fetner C, Barilla D, Townsend J, Pak C . Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. J Urol. 1978; 120(4):399-401. DOI: 10.1016/s0022-5347(17)57198-0. View

Pak C, Hayashi Y, Finlayson B, Chu S . Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods. J Lab Clin Med. 1977; 89(4):891-901. View

Robertson W, Peacock M, Nordin B . Activity products in stone-forming and non-stone-forming urine. Clin Sci. 1968; 34(3):579-94. View

Boyce W, KING Jr J . Present concepts concerning the origin of matrix and stones. Ann N Y Acad Sci. 1963; 104:563-78. DOI: 10.1111/j.1749-6632.1963.tb17693.x. View

Pak C . Effects of cellulose phosphate and sodium phosphate on formation product and activity product of brushite in urine. Metabolism. 1972; 21(5):447-55. DOI: 10.1016/0026-0495(72)90056-x. View

10.

Meyer J, Smith L . Growth of calcium oxalate crystals. I. A model for urinary stone growth. Invest Urol. 1975; 13(1):31-5. View

11.

VERMEULEN C, Lyon E, FRIED F . ON THE NATURE OF THE STONE-FORMING PROCESS. J Urol. 1965; 94:176-86. DOI: 10.1016/S0022-5347(17)63596-1. View

12.

Pak C . Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation product of brushite. Clin Pharmacol Ther. 1973; 14(2):209-17. DOI: 10.1002/cpt1973142209. View

13.

Francis M, Russell R, Fleisch H . Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. 1969; 165(3899):1264-6. DOI: 10.1126/science.165.3899.1264. View

14.

Boyce W, GARVEY F . The amount and nature of the organic matrix in urinary calculi: a review. J Urol. 1956; 76(3):213-27. DOI: 10.1016/S0022-5347(17)66686-2. View

15.

Hayashi Y, Kaplan R, Pak C . Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism. 1975; 24(11):1273-8. DOI: 10.1016/0026-0495(75)90065-7. View

16.

Woelfel A, Kaplan R, Pak C . Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine. Metabolism. 1977; 26(2):201-5. DOI: 10.1016/0026-0495(77)90056-7. View

17.

Fraser D, Russell R, Pohler O, Robertson W, Fleisch H . The influence of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats. Clin Sci. 1972; 42(2):197-207. DOI: 10.1042/cs0420197. View

18.

Bone 3rd H, Zerwekh J, Britton F, Pak C . Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards. J Urol. 1979; 121(5):568-71. DOI: 10.1016/s0022-5347(17)56883-4. View

19.

Oata M, Pak C . Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate. Metabolism. 1974; 23(12):1167-73. DOI: 10.1016/0026-0495(74)90033-x. View

20.

Boyce W . Organic matrix of human urinary concretions. Am J Med. 1968; 45(5):673-83. DOI: 10.1016/0002-9343(68)90203-9. View